X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (166) 166
index medicus (157) 157
hematology (147) 147
female (116) 116
male (113) 113
adult (112) 112
transplantation (95) 95
middle aged (92) 92
adolescent (73) 73
child (57) 57
bone-marrow-transplantation (56) 56
immunology (52) 52
hematopoietic stem cell transplantation (51) 51
hematopoietic stem cells (51) 51
stem cells (51) 51
young adult (49) 49
aged (47) 47
retrospective studies (47) 47
transplantation, homologous (47) 47
hematopoietic stem cell transplantation - adverse effects (44) 44
abridged index medicus (38) 38
versus-host-disease (38) 38
child, preschool (37) 37
treatment outcome (33) 33
analysis (29) 29
stem-cell transplantation (28) 28
life sciences (27) 27
mortality (27) 27
graft vs host disease - immunology (26) 26
hematology, oncology and palliative medicine (26) 26
bone marrow (25) 25
leukemia (25) 25
oncology (25) 25
chronic disease (24) 24
graft vs host disease - etiology (24) 24
blood (22) 22
follow-up studies (22) 22
risk factors (22) 22
aplastic anemia (21) 21
prognosis (21) 21
stem cell transplantation (21) 21
survival (20) 20
disease (17) 17
hematopoietic stem cell transplantation - methods (17) 17
human health and pathology (17) 17
recipients (17) 17
acute disease (16) 16
graft vs host disease - prevention & control (16) 16
immunosuppressive agents - therapeutic use (16) 16
incidence (16) 16
recurrence (16) 16
survival analysis (16) 16
survival rate (16) 16
transplantation conditioning - methods (16) 16
acute myeloid-leukemia (15) 15
anemia, aplastic - therapy (15) 15
bone-marrow (15) 15
diagnosis (15) 15
france (15) 15
hematologic neoplasms - therapy (15) 15
unrelated donors (15) 15
bone marrow transplantation (14) 14
risk (14) 14
allografts (13) 13
cancer (13) 13
graft vs host disease - mortality (13) 13
graft vs host disease - pathology (13) 13
multivariate analysis (13) 13
risk-factors (13) 13
time factors (13) 13
transplantation conditioning (13) 13
anemia (12) 12
care and treatment (12) 12
children (12) 12
immunosuppressive therapy (12) 12
infant (12) 12
leukemia, myeloid, acute - therapy (12) 12
outcomes (12) 12
paroxysmal nocturnal hemoglobinuria (12) 12
research (12) 12
surgery (12) 12
transplants & implants (12) 12
anemia, aplastic - mortality (11) 11
aplastic-anemia (11) 11
complications and side effects (11) 11
gvhd (11) 11
health aspects (11) 11
surgical procedures, operative (11) 11
antithymocyte globulin (10) 10
complement inhibitor eculizumab (10) 10
disease-free survival (10) 10
allogeneic hematopoietic stem cell transplantation (9) 9
antibodies, monoclonal - therapeutic use (9) 9
expression (9) 9
fludarabine (9) 9
graft vs host disease - drug therapy (9) 9
medical research (9) 9
medicine, experimental (9) 9
patients (9) 9
peripheral-blood (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1038 - 1038
Abstract Background/Objective: The association between paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size at disease onset and outcomes in... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3382 - 3382
Abstract Recipients of allogeneic hematopoietic stem cell transplant (HSCT) who have positive cytomegalovirus (CMV) serology are at increased risk for... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 797 - 797
Abstract Background: MDS and AML are mostly found in elderly patients. However, even in this population there is increasing evidence of predisposing genetic... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4007 - 4007
Abstract Background: High-risk (HR) AML including secondary AML (sAML) or therapy-related (tAML) are associated with significantly lower complete remission... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 626 - 626
Abstract Background/Objective: In 2 large, phase 3 clinical studies, ravulizumab (ALXN1210), an innovative C5 inhibitor administered every 8 weeks, achieved... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 916 - 916
Abstract The last three authors contributed equally to this work. Introduction: Allogeneic hematopoietic stem cell transplantation (HSCT) may improve long-term... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2498 - 2498
Background: Fanconi anemia (FA) is the most frequent genetic cause of bone marrow failure (BMF) due to a DNA repair mechanism defect. The natural history of FA... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 535 - 535
Abstract Introduction: SKY59 is an anti-C5 antibody applying SMART* [Fukuzawa et al., SciRep 2017] to allow for infrequent SC dosing. A three-part adaptive... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2330 - 2330
Abstract Background/Objective: Breakthrough hemolysis (BTH) is the return of hemolytic disease activity during treatment with complement C5 inhibitors for... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1305 - 1305
Abstract Introduction: Thrombopoietin receptor agonist eltrombopag (ELT) provides hematologic improvement in up to 50% of adults with acquired aplastic anemia... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2271 - 2271
The presence of cerebral macrovasculopathy as detected by transcranial Doppler (TCD) exposes children with sickle cell anemia (SCA) to a high risk of stroke,... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3458 - 3458
Abstract Background Many patients with relapsed or refractory Hodgkin's lymphoma (HL) undergo high-dose chemotherapy (HDC) and autologous stem cell... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 5881 - 5881
Abstract Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is the only curative treatment for many patients with hematologic disease. Unfortunately,... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2674 - 2674
Abstract Background: Optimization of transplantation modalities (Graft versus host disease (GVHD) prophylaxis, conditioning regimens, high level HLA typing and... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5069 - 5069
Abstract Background: In aplastic anemia (AA), antithymocyte globulin (ATG) plus ciclosporine (CsA) is an effective alternative to hematopoietic stem cell... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 2945 - 2945
Abstract In the absence of a matched sibling donor for patients with severe aplastic anemia (SAA), allogeneic hematopoietic stem cell transplantation... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4391 - 4391
Abstract Background. Fanconi anemia (FA) is a rare, phenotypically heterogeneous, inherited disorder clinically characterized by congenital abnormalities,... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 11, pp. 1032 - 1039
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.